Clinical Trial Update: A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older [Phase 3]

View source ↗

Summary

Phase 3 trial assessing an Ad26.RSV.preF-based RSV vaccine with and without coadministration of a high-dose seasonal influenza vaccine in adults 65 and older; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Ad26.RSV.preF-based vaccine (Ad26.RSV.preF)
• Fluzone High-Dose influenza vaccine (Fluzone High-Dose)

Snippet

Sponsor: Janssen Vaccines & Prevention B.V. | Conditions: Influenza, Human Prevention, Respiratory Syncytial Viruses Prevention | Phase 3 | Status: COMPLETED | Results posted: 2023-09-13